Liabilities of ProQR Therapeutics N.V. from 31 Dec 2016 to 30 Sep 2024

Taxonomy & unit
ifrs-full: EUR
Summary
ProQR Therapeutics N.V. quarterly Liabilities in EUR history and change rate from 31 Dec 2016 to 30 Sep 2024.
  • ProQR Therapeutics N.V. Liabilities for the quarter ending 30 Sep 2024 was €81,869,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (EUR)
Liabilities, YoY Quarterly Change (%)

ProQR Therapeutics N.V. Quarterly Liabilities (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 €81,869,000 -€13,825,000 -14% 30 Sep 2024 6-K 07 Nov 2024 2024 Q3
Q2 2024 €85,197,000 -€11,293,000 -12% 30 Jun 2024 6-K 08 Aug 2024 2024 Q2
Q1 2024 €89,055,000 -€10,256,000 -10% 31 Mar 2024 6-K 09 May 2024 2024 Q1
Q4 2023 €96,493,000 -€8,147,000 -7.8% 31 Dec 2023 6-K 07 Nov 2024 2024 Q3
Q3 2023 €95,694,000 +€38,501,000 +67% 30 Sep 2023 6-K 07 Nov 2023 2023 Q3
Q2 2023 €96,490,000 +€4,411,000 +4.8% 30 Jun 2023 6-K 03 Aug 2023 2023 Q2
Q1 2023 €99,311,000 +€9,295,000 +10% 31 Mar 2023 6-K 16 May 2023 2023 Q1
Q4 2022 €104,640,000 +€8,290,000 +8.6% 31 Dec 2022 20-F 13 Mar 2024 2023 FY
Q3 2022 €57,193,000 -€10,117,000 -15% 30 Sep 2022 6-K 09 Nov 2022 2022 Q3
Q2 2022 €92,079,000 +€47,265,000 +105% 30 Jun 2022 6-K 04 Aug 2022 2022 Q2
Q1 2022 €90,016,000 31 Mar 2022 6-K 05 May 2022 2022 Q1
Q4 2021 €96,350,000 +€54,167,000 +128% 31 Dec 2021 20-F 29 Mar 2023 2022 FY
Q3 2021 €67,310,000 +€25,210,000 +60% 30 Sep 2021 6-K 04 Nov 2021 2021 Q3
Q2 2021 €44,814,000 +€30,882,000 +222% 30 Jun 2021 6-K 05 Aug 2021 2021 Q2
Q4 2020 €42,183,000 +€18,481,000 +78% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q3 2020 €42,100,000 +€20,455,000 +95% 30 Sep 2020 6-K 16 Nov 2020 2020 Q3
Q2 2020 €13,932,000 -€6,086,000 -30% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q1 2020 €22,284,000 31 Mar 2020 6-K 07 May 2020 2020 Q1
Q4 2019 €23,702,000 +€6,156,000 +35% 31 Dec 2019 20-F 24 Mar 2021 2020 FY
Q3 2019 €21,645,000 30 Sep 2019 6-K 12 Nov 2019 2019 Q3
Q2 2019 €20,018,000 +€5,208,000 +35% 30 Jun 2019 6-K 07 Aug 2019 2019 H1
Q4 2018 €17,546,000 +€3,768,000 +27% 31 Dec 2018 20-F 31 Mar 2020 2019 FY
Q2 2018 €14,810,000 30 Jun 2018 6-K 08 Aug 2018 2018 Q2
Q4 2017 €13,778,000 +€1,371,000 +11% 31 Dec 2017 20-F 28 Mar 2019 2018 FY
Q4 2016 €12,407,000 31 Dec 2016 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.